COMBINATION OF NIRAPARIB AND ANLOTINIB IN PATIENTS WITH RECURRENT OR METASTATIC ENDOMETRIAL CANCER: AN OPEN-LABEL, SINGLE-ARM, TWO-STAGE, PHASE II STUDY

被引：0
|
作者：
Ren, Yulan [1 ,2 ]
Lu, Jing [2 ,3 ]
Tian, Wenjuan [1 ,2 ]
Li, Haiming [2 ,3 ]
Wang, Huaying [1 ,2 ]
机构：
[1] Fudan Univ, Dept Gynecol Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai Canc Ctr, Shanghai, Peoples R China
[3] Fudan Univ, Dept Radiol, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2022年 / 32卷
关键词：
D O I：
10.1136/ijgc-2022-igcs.239
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP148/#437
引用
收藏
页码：A107 / A107
页数：1
相关论文
共 50 条
  • [21] Tucidinostat plus toripalimab in patients with unresectable or metastatic melanoma: An open-label, single-arm phase II study
    Mao, Lili
    Dai, Jie
    Bai, Xue
    Kong, Yan
    Sheng, Xinan
    Chi, Zhihong
    Cui, Chuanliang
    Lian, Bin
    Tang, Bixia
    Yan, Xieqiao
    Wang, Xuan
    Li, Siming
    Zhou, Li
    Wei, Xiaoting
    Li, Juan
    Li, Caili
    Duan, Rong
    Xu, Huayan
    Guo, Jun
    Si, Lu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] Open-label, single-arm, phase II study of enzastaurin in patients with follicular lymphoma
    Schwartzberg, Lee
    Hermann, Robert
    Flinn, Ian
    Flora, Douglas
    Hsi, Eric D.
    Hamid, Oday
    Shi, Peipei
    Lin, Boris K.
    Myrand, Scott P.
    Nguyen, Tuan S.
    Dreyling, Martin
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 166 (01) : 91 - 97
  • [23] Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: A multicenter, open-label, single-arm, phase II study
    Wu, X.
    Xia, L.
    Wang, J.
    Wang, C.
    Zhang, Q.
    Zhu, J.
    Rao, Q.
    Cheng, H.
    Liu, Z.
    Yin, Y.
    Ai, X.
    Gulina, K.
    Zheng, H.
    Luo, X.
    Chang, B.
    Li, L.
    Liu, H.
    Li, Y.
    Zhu, J.
    ANNALS OF ONCOLOGY, 2022, 33 : S1506 - S1506
  • [24] EFFICACY AND SAFETY OF ZIMBERELIMAB (GLS-010) MONOTHERAPY IN PATIENTS WITH RECURRENT OR METASTATIC CERVICAL CANCER: A MULTICENTER, OPEN-LABEL, SINGLE-ARM, PHASE II STUDY
    Wu, Xiaohua
    Xia, Lingfang
    Wang, Jing
    Wang, Chunyan
    Zhang, Qingming
    Zhu, Jianqing
    Rao, Qunxian
    Cheng, Huijun
    Liu, Zheng
    Yin, Yongmei
    Ai, Xiaohong
    Gulina, Kurban
    Zheng, Hong
    Luo, Xiaoyong
    Chang, Baoping
    Li, Li
    Liu, Haiyan
    Li, Yunxia
    Lou, Ge
    Zhou, Qi
    Zhu, Yanling
    Xiao, Zemin
    Tong, Jiandong
    Wang, Ke
    Chen, Jie
    Wang, Xia
    Song, Lijie
    Wei, Zhixia
    Ye, Yijing
    Zhu, Jiman
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A703 - A703
  • [25] Safety and Efficacy of Apatinib Monotherapy for Unresectable, Metastatic Esophageal Cancer: A Single-Arm, Open-Label, Phase II Study
    Li Yanwei
    Feng, He
    Ren, Peng
    Yue, Jie
    Zhang, Wencheng
    Tang, Peng
    Shang, Xiaobin
    Pang, Qingsong
    Liu, Dongying
    Chen, Chuangui
    Pan, Zhanyu
    Tao, Yu Zhen
    ONCOLOGIST, 2020, 25 (10): : E1464 - E1472
  • [26] Anlotinib plus pemetrexed as a further treatment for patients with platinum-resistant ovarian cancer: A single-arm, open-label, phase II study.
    Chen, Jueming
    Wei, Wei
    Zheng, Lie
    Li, Han
    Feng, Yanling
    Wan, Ting
    Qiu, Jiaqi
    Jiang, Xingyu
    Xiong, Ying
    Zheng, Min
    Li, Jundong
    Huang, He
    Song, Libing
    Liu, Jihong
    Zhang, Yanna
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [27] Efficacy and safety of niraparib combined with anlotinib maintenance retreatment in platinum-sensitive recurrent ovarian cancer patients who previously received PARP inhibitor: An open-label, single-arm, prospective, exploratory phase II study
    Jin, Ying
    Pan, Lingya
    Shan, Ying
    Li, Yan
    Gu, Yu
    Wang, Wei
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S168 - S168
  • [28] An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma
    Agulnik, Mark
    Schulte, Brian
    Robinson, Steven
    Hirbe, Angela C.
    Kozak, Kevin
    Chawla, Sant P.
    Attia, Steven
    Rademaker, Alfred
    Zhang, Hui
    Abbinanti, Susan
    Cehic, Rasima
    Monga, Varun
    Milhem, Mohammed
    Okuno, Scott
    Van Tine, Brian A.
    EUROPEAN JOURNAL OF CANCER, 2021, 154 : 201 - 208
  • [29] Anlotinib (AL3818) plus pemetrexed in patients with recurrent platinum-resistant advanced epithelial ovarian cancer: A single-arm, open-label, phase II study.
    Zhang, Yanna
    Chen, Jueming
    Wei, Wei
    Zheng, Lie
    Li, Han
    Feng, Yanling
    Wan, Ting
    Qiu, Jiaqi
    Jiang, Xingyu
    Xiong, Ying
    Li, Jundong
    Song, Libing
    Liu, Jihong
    Huang, He
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [30] Regorafenib-avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial
    Cousin, Sophie
    Cantarel, Coralie
    Guegan, Jean-Philippe
    Mazard, Thibault
    Gomez-Roca, Carlos
    Metges, Jean-Philippe
    Bellera, Carine
    Adenis, Antoine
    Korakis, Iphigenie
    Poureau, Pierre-Guillaume
    Bourcier, Kevin
    Toulmonde, Maud
    Kind, Michele
    Rey, Christophe
    Auzanneau, Celine
    Bessede, Alban
    Soubeyran, Isabelle
    Italiano, Antoine
    EUROPEAN JOURNAL OF CANCER, 2022, 162 : 161 - 169
12345